Generation Bio GBIO 深 沪
等待开盘 11-10 09:30:00 美东时间
5.11
+0.090
+1.79%
华盛通- 最 高5.12
- 今 开5.03
- 成交量 4.18万股
- 最 低 4.93
- 昨 收 5.02
- 总市值 3441.84万
- 52周最高 16.792
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.004
- 委 比 -64.80%
- 总股本 673.55万
- 历史最高 557.20
- 量 比 0.30
- 振 幅 3.78%
- 历史最低 3.004
- 每 手 1
- 风险率 3.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Generation Bio Announces Third Quarter 2025 Financial Results
Generation Bio Co reported its third quarter 2025 financial results. Cash stood at $89.6 million, down from $185.2 million in 2024. R&D expenses rose to $21.7 million, up from $15.1 million. G&A costs increased to $12.2 million from $9.2 million. Net loss narrowed to $5.5 million ($0.82 per share) from $15.3 million ($2.29 per share) in 2024. The company settled a lease dispute by paying $31 million and recorded a $25.5 million gain. Generation B...
11-05 21:05
Generation Bio CEO Resignation and Leadership Transition
Generation Bio ( ($GBIO) ) has issued an update. On October 21, 2025, Generatio...
10-23 04:29
Generation Bio President, CEO Geoff McDonough To Become Board Chair, Effective Oct. 31; Yalonda Howze Names Interim CEO, President
Generation Bio Co. (NASDAQ:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases, today announced that Geoff McDonough, MD will step down as Chief
10-23 04:09
2025 Q3生物制药裁员汇总
（来源：药研网） 金秋十月，凉风拂过，却未能带来行业期盼已久的复苏。 国外媒体Fierce Biotech 最新数据显示，刚过去的第三季度，共发生 62 起裁员...
10-09 14:47
美股牛股 | Bullish上市首日飙升83%，手握2.4万枚比特币；大麻股Tilray涨超30%
加密货币交易所Bullish上市首日飙升83%，手握2.4万枚比特币；大麻股Tilray隔夜涨超30%，周内涨超90%，特朗普拟将大麻改为低危药物>>
08-14 15:08
美股大行评级 | 潜在涨幅95.33%！HC Wainwright & Co.上调Insmed目标价至240美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Insmed"买入"评级，目标价从120美元升至240美元；巴克莱：维持Transocean"超配"评级，目标价从3.5美元升至4美元
08-14 09:25
Generation Bio Q2 EPS $(3.12) Misses $(2.62) Estimate, Sales $765.000K Miss $2.139M Estimate
Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(3.12) per share which missed the analyst consensus estimate of $(2.62) by 19.08 percent. This is a 906.45 percent decrease over losses of $(0.31) per share from
08-13 05:38
Generation Bio shares are trading higher after the company announced new data demonstrating that its cell-targeted lipid nanoparticle system selectively delivered siRNA to T cells in non-human primates.
Generation Bio shares are trading higher after the company announced new data d...
08-13 04:25
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
Generation Bio announced new data demonstrating their cell-targeted lipid nanoparticle (ctLNP) system successfully delivered siRNA to T cells in non-human primates, a first in the field. The system showed potent and selective knockdown of beta-2 microglobulin, LAT1, and VAV1, potentially addressing T cell-driven autoimmune diseases. The company reported a cash balance of $141.4 million as of June 30, 2025, and is evaluating strategic alternatives...
08-12 20:05
Generation Bio shares are trading higher after the company announced it has been granted Australian Patent Number 2019210034 titled "Closed-ended DNA vectors obtainable from cell-free synthesis and process for obtaining ceDNA vectors (for gene therapy)"
Generation Bio shares are trading higher after the company announced it has bee...
07-26 02:44
